UnitedHealth Group reported strong Q1 2016 results, with revenues up 24% to $44.5 billion and adjusted earnings per share increasing by 17% year over year. The company raised its full-year revenue and EPS outlook, highlighting exceptional performance in its Optum segment and strong growth in Medicare Advantage membership. Despite challenges in the ACA exchange business, the company's overall positive performance and increased guidance suggest a favorable short-term impact on the stock.

[1]